Category Archives: Tomi

TOMI’s SteraMist(TM). Environment System News

Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE

Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE

Interactive map from Johns Hopkins University shows the effects of coronavirus in real time.

The dashboard embedded here is published and hosted by researchers at the Center for Systems Science and Engineering, Johns Hopkins University. It shows the number and location of confirmed COVID-19 cases, deaths, and recoveries in all affected countries.

The researchers have the intention to “continue hosting and managing the tool throughout the entirety of the COVID-19 outbreak”.

Scientific Paper: The background paper for the Johns Hopkins’ dashboard was published by Dong, Du, and Gardner (2020) in The Lancet Infectious Disease.9 This paper also includes a comparison of this data with the data reported by the WHO and the Chinese CDC.

Data: All collected data in this effort from the Johns Hopkins University is made freely available by the researchers through this GitHub repository. You can download all the data shown in the embedded dashboard. Information on the sources of their data can also be found directly there.

Mobile-friendly dashboard: A mobile friendly version of the embedded dashboard is here.

Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE

COVID-19. SteraMist® Declared Official Decontamination Technology of Seoul City Metropolitan Transit Systems

COVID-19. SteraMist® Declared Official Decontamination Technology of Seoul City Metropolitan Transit Systems

In the continuing effort to combat coronavirus (COVID-19) both overseas and domestically, SteraMist® has officially been declared the official decontamination technology of the Seoul City Metro Transit in South Korea.

TOMI™ Steramist™ Press Release

South Korea’s national total of COVID-19 cases has grown to over 4,000 according the South Korean Centers for Disease Control and Prevention (KCDC). Detecting the early stages of COVID-19 infection can prove to be difficult, and direct contact with the virus that are on common surfaces such as railings, vending machines and train seats in rapid transit systems worldwide are thought to be a mechanism for transference.

An established five-year TOMI authorized distributor in South Korea, GD Sciences, has begun to address this problem by utilizing SteraMist® technology in transit systems, focusing primarily on the metropolitan transit system of South Korea’s capital city, Seoul. The annual ridership of the Seoul Metropolitan Subway is over 1.2 billion. This application has allowed SteraMist® to become a critical line of defense as a preventative measure against the rapid spread of COVID-19.

Joseph So, the CEO of GD Sciences, states, “We experienced a similar outbreak with MERS years ago and have dealt with these types of infectious disease outbreaks in the past. The number of confirmed patients is higher than five years ago, but rest assured that Seoul’s Metro System is in safe hands with the use of SteraMist® decontamination equipment and its rapid ease of application with six-log (99.9999%) efficacy.”

On-site application of SteraMist® has been tested throughout transportation venues in the metro subway trains, treating surfaces such as seating, handles, vending machines, walls, floors, and doors. Joining the workers treating the area with SteraMist® was Seoul’s mayor, Park Won-soon. Seeing the success of SteraMist® disinfection, the mayor has hired GD Science to service the Seoul Metropolitan Rapid Transit Corporation (SMRT).

TOMI’s CEO, Dr. Halden Shane, states, “We are pleased to announce this opportunity to help protect the city of Seoul and fight the ongoing threat of COVID-19 by ensuring a healthier transit environment through SteraMist®. Just as new cases of infection are continuously growing in countries around the world, this is yet another step in our commitment to global cooperation as we continue to innovate for a safer world in the face of new and existing pathogen threats.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For more information, visit tomimist.com

Steramist Disinfection Service offered for:

Your Office Space

Your High Concern Areas

Your High Traffic Areas

Request a Quote

SteraMist® Takes the Fight to the Coronavirus Worldwide – China, Hong Kong, Thailand, Singapore, Israel and the United Kingdom

SteraMist® Takes the Fight to the Coronavirus Worldwide – China, Hong Kong, Thailand, Singapore, Israel and the United Kingdom.

TOMI™ Steramist™ Press Release

Already EPA-registered on lists J, K, G, and L, which include H1N1 or Influenza A (enveloped) and Norovirus (non-enveloped), TOMI anticipates to secure listing in the EPA’s upcoming publication of Emerging Pathogen Lists, which includes COVID-19. SteraMist® was also featured as the only disinfectant product in the World Health Organization Compendium of Innovative Health Technologies.

SteraMist® is now the industry standard throughout China after TOMI recently received approval and registration for two (2) separate registrations – SteraMist® equipment registration and BIT solution registration – from the Chinese Center for Disease Control and Prevention (China CDC). With the latest outbreak, China is able to take advantage of SteraMist® disinfection and its ability to rapidly deploy throughout the country as needed. TOMI is finalizing negotiations with high-level Chinese officials for use of the SteraMist® Surface Unit in aiding the control of COVID-19.

Routinely used to disinfect high traffic areas, SteraMist® iHP technology has treated public transportation, ambulances, hotel rooms, offices, and universities to stop the spread of this virus. With more than 50 international customers and partners ranging from countries in Asia, Europe, and the Mideast using hundreds of SteraMist® units, many of which have been deployed to stop the spread of COVID-19.

Recently, TOMI has signed on a new distribution partner in Thailand, more news will be coming shortly. TOMI has also shipped a number of units to Hong Kong to assist with new innovative ways of helping Hong Kong with their ongoing battle of controlling COVID-19.

In addition to one of the many cases worldwide, a hotel in York became the first in the United Kingdom to test positive for COVID-19. After receiving approval from the Public Health of England, SteraMist® was used to treat the hotel room and was quickly validated by Enzyme Indicators (EIs). The treatment was a resounding success: the room was disinfected with a 9-log inactivation, exceeding the 6-log inactivation required.

Similarly, TOMI was also easily able to deploy SteraMist® in one of eight recent cases in Singapore, one of which included a professor at the National University of Singapore (NUS) upon realizing they were contagious with COVID-19. The Ministry of Health proceeded to take action to stop the spread of the virus on campus, with the university president calling on SteraMist® to thoroughly disinfect the facility. SteraMist® was used in high traffic areas, such as hand railings, lifts, and lift lobbies, and routine facility cleaning was increased from two times a day to four times a day. Quick response allowed for thorough disinfection and continued preventative measures to protect both students and staff at risk of contracting the virus.

Yaki Agam, CEO of CleanBit Ltd., TOMI’s partner in Israel, states, “Just recently, the eleven (11) Israeli passengers who were on the Diamond Princess cruise ship returned to Israel after being suspected of carrying the virus. Two passengers were confirmed to be infected, further transferring coronavirus to Israel.CleanBit was selected by the Ministry of Health and the Israeli government to disinfect the aircraft, ambulances, and buses in which the infected passengers arrived from the ship in Japan to the hospital in Israel.”

As of today, CleanBit is disinfecting the hospital isolation facility and the surrounding areas on a daily basis where infected passengers are currently staying. TOMI’s Israeli partner is on national alert to assist in an emergency situation by using SteraMist to disinfect in the event coronavirus might erupt nationwide.Recently, agreements have been signed between CleanBit Ltd., the Ministry of Defense, and Magen David Adom (Israeli equivalent of the American Red Cross organization), including fire departments, airports, and two major hospitals for service with SteraMist® disinfection assisting in stopping the spread of coronavirus.

TOMI’s CEO, Dr. Halden Shane, states, “This is only a snapshot of the continued efforts we are making to stop the spread of coronavirus worldwide. The strong demand for our SteraMist® surface unit is rapidly depleting our inventory – although we have an ample supply of SteraMist® BIT solution. Accordingly, in anticipation of this continuing demand, TOMI™ has placed orders with our manufacturer for additional surface units on an expedited basis, in an effort to meet both our short-term and long-term demand. This is a dangerous virus that may remain on surfaces for at least nine (9) days and should not to be underestimated. COVID-19 will most likely be with us for a long time, maybe years.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For more information, visit tomimist.com

 

TOMI Receives China CDC Registration Making SteraMist® the Disinfection Industry Standard in China

Effective immediately, SteraMist® equipment and BIT solution has been registered with the Chinese Center for Disease Control and Prevention (China CDC).

TOMI™ Steramist™ Press Release

After a three (3) year-long submission process, TOMI recently received confirmation that two (2) separate registrations – SteraMist® equipment registration and BIT solution registration – have now been officially approved and registered with the China CDC.

SteraMist® is now the industry standard for disinfection throughout all of China. This registration allows China to take advantage of SteraMist® disinfection and decontamination in a variety of verticals such as healthcare, pharmaceutical, commercial and residential, schools, and throughout the community.

With the latest outbreak of coronavirus 2019-nCoV, TOMI is able to rapidly deploy SteraMist® throughout the country as needed and requested. China’s registration adds to the long list of countries in which TOMI is registered and utilized.

TOMI’s CEO, Dr. Halden Shane, states “TOMI is excited to announced that we are now registered with the China CDC.  Throughout the world, SteraMist® is used to eradicate enveloped viruses, similar to coronavirus, and is the superior disinfection for use in spaces such as transportation avenues, hospitals, and other emergency areas. After a long registration process, SteraMist® is the industry standard and future of disinfection and decontamination throughout China, which is a substantial milestone for our company.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of  ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist®® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

INVESTOR RELATIONS CONTACT

Harold Paul
hpaul@tomimist.com

SteraMist® features efficacy against Influenza A and similar, enveloped viral threat including 2019-nCoV, the current coronavirus outbreak.

EFFICACY AGAINST CORONAVIRUS?

TOMI™ Steramist™ Press Release

Similar to Influenza A, coronavirus is an enveloped virus. While this would often serve to protect the virus from possible threats, SteraMist® features efficacy against Influenza A and similar, enveloped viral threat including coronavirus.

TOMI has EPA accepted studies on the current label to meet the standard to respond to emerging pathogens in the enveloped and non-enveloped categories, which include, SARS, MERS and 2019-nCoV, the current coronavirus outbreak*.

*For more information, see EPA Registration #90150-2

For more information, visit tomimist.com